- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/553 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
Patent holdings for IPC class C07F 9/553
Total number of patents in this class: 42
10-year publication summary
|
1
|
3
|
2
|
2
|
3
|
7
|
0
|
2
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ventana Medical Systems, Inc. | 1057 |
5 |
| Board of Regents, The University of Texas System | 6018 |
3 |
| Shanghai Shengdi Pharmaceutical Co., Ltd | 146 |
3 |
| Shanghai Senhui Medicine Co., Ltd. | 81 |
3 |
| Cancer Targeted Technology LLC | 28 |
2 |
| Nour Heart, Inc. | 16 |
2 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 237 |
2 |
| The Trustees of Columbia University in the City of New York | 3608 |
1 |
| Baylor College of Medicine | 986 |
1 |
| Dalhousie University | 168 |
1 |
| Duk San Neolux Co., Ltd. | 676 |
1 |
| Gilead Sciences, Inc. | 2177 |
1 |
| Hangzhou DAC Biotech Co., Ltd | 108 |
1 |
| Jiangsu Hengyi Pharmaceutical Co., Ltd. | 284 |
1 |
| Morphochem Aktiengesellschaft fuer Kombinatorische Chemie | 3 |
1 |
| Nard Institute, Ltd. | 16 |
1 |
| National University Corporation Nagoya University | 813 |
1 |
| Otsuka Pharmaceutical Co., Ltd. | 1499 |
1 |
| Pentracor GmbH | 18 |
1 |
| Ruhr-Universität Bochum | 92 |
1 |
| Other owners | 9 |